Valeant to buy contact-lens giant Bausch & Lomb for $4.5 billion – Los Angeles Times
|
Valeant to buy contact-lens giant Bausch & Lomb for $ 4.5 billion
Los Angeles Times Valeant Pharmaceuticals International Inc., Canada's largest publicly traded drug maker, is continuing an acquisition spree with an agreement to buy eye-care giant Bausch & Lomb Holdings Inc. for $ 4.5 billion. The Montreal company, which announced the … Valeant Agrees to Buy Bausch & Lomb in $ 8.7 Billion Deal Valeant to Buy Bausch & Lomb for $ 8.7 Billion $ 9 Billion Bausch & Lomb Sale Mints New Turnaround Artist |
